# NEPA in Patients With HER2-positive or HER2-low Advanced Breast Cancer Treated With T-DXd

> **NCT07132749** · — · ENROLLING_BY_INVITATION · sponsor: **Yeon Hee Park** · enrollment: 100 (estimated)

## Conditions studied

- Patients With HER2-positive Advanced Breast Cancer Treated With T-DXd
- Patients With HER2-low Advanced Breast Cancer Treated With T-DXd

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07132749
- **Lead sponsor:** Yeon Hee Park
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-08-12
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-01-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07132749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07132749, "NEPA in Patients With HER2-positive or HER2-low Advanced Breast Cancer Treated With T-DXd". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07132749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*